150 related articles for article (PubMed ID: 7846108)
1. Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase.
Rizk M; Abdel-Rahman MS
Prostaglandins Leukot Essent Fatty Acids; 1994 Nov; 51(5):363-7. PubMed ID: 7846108
[TBL] [Abstract][Full Text] [Related]
2. Effects and interaction studies of triflusal and other salicylic derivatives on cyclooxygenase in rats.
De Castellarnau C; Sancho MJ; Vila L; Albors M; Rutllant ML
Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):83-9. PubMed ID: 3128800
[TBL] [Abstract][Full Text] [Related]
3. Salicylates and 12-lipoxygenase activity in human washed platelets.
Radomski M; Michalska Z; Marcinkiewicz E; Gryglewski RJ
Pharmacol Res Commun; 1986 Nov; 18(11):1015-30. PubMed ID: 3797446
[TBL] [Abstract][Full Text] [Related]
4. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
Ali M; McDonald JW
Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
[TBL] [Abstract][Full Text] [Related]
5. Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.
de la Cruz JP; Mata JM; Sanchez de la Cuesta F
Gen Pharmacol; 1992 Mar; 23(2):297-300. PubMed ID: 1639242
[TBL] [Abstract][Full Text] [Related]
6. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites.
Rotilio D; Joseph D; Hatmi M; Vargaftig BB
Eur J Pharmacol; 1984 Jan; 97(3-4):197-208. PubMed ID: 6423393
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
[No Abstract] [Full Text] [Related]
9. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin.
Rao GH; Johnson GG; Reddy KR; White JG
Arteriosclerosis; 1983; 3(4):383-8. PubMed ID: 6411052
[TBL] [Abstract][Full Text] [Related]
10. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate.
Hernández R; Alemany M; Bozzo J; Buchanan MR; Ordinas A; Bastida E
Haemostasis; 1993; 23(1):1-7. PubMed ID: 8477903
[TBL] [Abstract][Full Text] [Related]
11. Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase.
Rao GH; Reddy KR; White JG
Prostaglandins Leukot Med; 1982 Jul; 9(1):109-15. PubMed ID: 6813873
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
13. Inter-individual variations of the effect of low dose aspirin regime on platelet cyclooxygenase activity.
Beving H; Eksborg S; Malmgren RS; Nordlander R; Rydén L; Olsson P
Thromb Res; 1994 Apr; 74(1):39-51. PubMed ID: 8029807
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines.
Vargaftig BB
Eur J Pharmacol; 1978 Aug; 50(3):231-41. PubMed ID: 99321
[TBL] [Abstract][Full Text] [Related]
15. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
Rao GH; Radh E; Johnson GJ; White JG
Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
[TBL] [Abstract][Full Text] [Related]
16. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
[TBL] [Abstract][Full Text] [Related]
18. Salicylic acid inhibition of the irreversible effect of acetylsalicyclic aicd on prostaglandin synthetase may be due to competition for the enzyme cationic binding site.
Peterson DA; Gerrard JM; Rao GH; White JG
Prostaglandins Med; 1981 Feb; 6(2):161-4. PubMed ID: 6787630
[TBL] [Abstract][Full Text] [Related]
19. Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings.
Crescente M; Cerletti C; de Gaetano G
Thromb Haemost; 2007 Jun; 97(6):1054-6. PubMed ID: 17549313
[No Abstract] [Full Text] [Related]
20. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
Halushka MK; Walker LP; Halushka PV
Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
